Systemic hypothermia to prevent radiocontrast nephropathy (from the COOL-RCN Randomized Trial).


Radiocontrast nephropathy (RCN) develops in a substantial proportion of patients with chronic kidney disease (CKD) after invasive cardiology procedures and is strongly associated with subsequent mortality and adverse outcomes. We sought to determine whether systemic hypothermia is effective in preventing RCN in patients with CKD. Patients at risk for RCN… (More)
DOI: 10.1016/j.amjcard.2011.04.026